进入MD-PhD课程的招生:应用指标如何预测短期或长期的医生科学家结果?
Lawrence F Brass1, Maurizio Tomaiuolo2, Aislinn Wallace3
1Department of Medicine and Pharmacology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
JCI insight
|March 4, 2025
概括
传统的入学指标并不能预测MD-PhD课程的成功. 申请人数据,包括GPA和测试成绩,未能预测医生科学家的培训表现或职业成果.
科学领域:
- 医学教育 医学教育
- 生物医学研究培训培训
- 医生科学家发展计划
背景情况:
- 医学博士学位课程旨在培养学术医学和生物医学研究领域的未来领导者.
- 招生委员会面临的挑战是从申请者池中选择成功的候选人.
- 传统的指标,如GPA和MCAT成绩经常被使用,尽管鼓励整体审查.
研究的目的:
- 为了确定是否预录取指标预测MD-PhD课程的表现和长期的职业成功.
- 评估各种申请人特征对培训成果和研究生产力的预测能力.
主要方法:
- 分析了来自国家MD-PhD课程成果研究和宾夕法尼亚-爱因斯坦数据集 (分别为4,659和593名校友) 的数据.
- 包括诸如GPA,MCAT分数,申请人人口统计和招生委员会分数等指标.
- 利用机器学习和多变量线性回归来分析程序中的性能,出版影响,学位的时间,就业和研究努力.
主要成果:
- 没有单个或组合的申请人指标有效预测了程序中的表现.
- 招生数据与未来的研究努力或毕业后的职业选择没有相关性.
- 这些发现甚至在比较申请人指标的顶部和底部五分之一的候选人时也是如此.
结论:
- 传统的申请人指标缺乏MD-PhD课程成功和医生科学家职业发展轨迹的预测有效性.
- 重新考虑录取标准可能是必要的,以更好地识别具有在学术医学领域领导潜力的候选人.
- 应优先考虑整体审查流程,以选择能够在以研究为重点的医学职业生涯中表现出色的个人.
相关概念视频
01:24Kaplan-Meier Approach
75
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
75
01:52Regression Toward the Mean
6.3K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.3K
01:20Comparing the Survival Analysis of Two or More Groups
117
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
117
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
111
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
111
01:13Sensitivity, Specificity, and Predicted Value
158
In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
Sensitivity is the...
158
01:21Cancer Survival Analysis
319
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
319